Tissue engineering and regenerative medicine in lung from basic to clinical

  • سال انتشار: 1397
  • محل انتشار: اولین کنگره بین المللی مهندسی بافت و پزشکی بازساختی ایران
  • کد COI اختصاصی: ITERMED01_411
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 507
دانلود فایل این مقاله

نویسندگان

Mostafa Ghanei

Chemical Injuries Research Center and Department of Pulmonary Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

Eisa Tahmasbpour

Laboratory of Regenerative Medicine and Biomedical Innovations, Pasteur Institute of Iran, Tehran, Iran.

Hossein Shahsavarani

Laboratory of Regenerative Medicine and Biomedical Innovations, Pasteur Institute of Iran, Tehran, Iran.

چکیده

Introduction Respiratory system is one of the most important and complex systems because not only it has a very special function, but also it is frequently exposed to some risk factors such as dust particles, granules of carbon, toxic gasesthat adversely affect its normal function. Therefore, it is important to find an appropriate strategy for lung regeneration and treatment of lung injuries. Objectives Here, we aim to review new advances, especially stem cell based therapy, in lung regeneration and function. Methods Different types of stem cells such as human embryonic stem cells, Mesenchymal stem cells, endothelial progenitor cells, and induced-pluripotent stem cells have been used for lung regeneration. Results The ability of stem cells to be migrated in lungs and converted to epithelial cells is a controversial issue which has been studied in recent years. It is assumed that stem cells injection can be replaced instead of damaged progenitor cells, which in turn associated with production of functional epithelial cells. Functional epithelial cells are able to prevent airway remodeling and provide a static condition to reproduce functional epithelial cells. Conclusion Unlike chemical drugs, the differentiation and high-level safety properties of stem cells can be considered as a new strategy for treatment of pulmonary complications

کلیدواژه ها

Lung regeneration, Stem cells, Lung diseases, Airway remodeling, Inflammation

مقالات مرتبط جدید

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.